InvestorsHub Logo
Followers 831
Posts 120054
Boards Moderated 17
Alias Born 09/05/2002

Re: None

Tuesday, 10/20/2015 10:44:05 AM

Tuesday, October 20, 2015 10:44:05 AM

Post# of 3022
ABBV/ENTA next-gen *8-week* regimen had 100% SVR4 in GT1 patients (late-breaking AASLD abstract):

#msg-117845374

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News